From Monitoring to
Life-Saving Intervention
Our Partners:
17B
Respiratory
Infections Annually
$19K
Cost Per Episode
Exacerbation Costs For High-Risk Patients
90%
Could Be Prevented
with Early Detection
Sensifai predicts immune system activity before it escalates into clinical complications, giving patients and providers the chance to intervene early.
Using off-the-shelf wearables,
we deliver early, life-saving insights to payers, providers, pharma,
and digital health platforms.
From Clinical Care
to Consumer Wellness:
Our platform scales from
high-risk medical monitoring
to population-wide health optimization.
The first to merge inflammatory biomarkers, AI, and every day wearables, turning raw data into life-saving early warnings.
Individuals use any
off-the-shelf wearable
AI analyzes physiological signals for inflammation patterns
AI correlates data with a personalized composite inflammation score
Individual and
clinician alerts
Intervene before
symptoms appear
We provide AI-powered inflammation detection technology to healthcare systems, pharma, and wearable companies enabling proactive health capabilities within your existing solutions.
Our proprietary AI is trained on a unique bio-
90%
sensitivity in predicting inflammation surges — proven in controlled clinical trials1
1. Hadid et al., The Lancet Digital Health, 2025
2 billion
The tool every physician needs:
AI that converts passive wearable signals into pre-symptomatic treatment before events begin.